The management and treatment of patients with advanced unresectable hepatocellular carcinoma (HCC)

Dr David Pinato is a Clinician Scientist and Consultant Medical Oncologist supported by the Wellcome Trust Strategic Fund (IPPRF scheme) working within the Department of Surgery and Cancer at Imperial College, London. Dr Pinato leads a translational research program focusing on the early clinical implementation of novel experimental anticancer therapies to the clinic, with particular emphasis on anti-cancer immunotherapy. He has led the inception of a portfolio of first-in-class studies of immune checkpoint inhibitors in liver cancer, which has represented David’s focus of research since graduation.

Dr Rohini Sharma is a Reader in Clinical Pharmacology and Medical Oncology. She is also a Consultant Medical Oncologist based at the Hammersmith Hospital campus of Imperial College Healthcare NHS Trust. Her clinical and research interests are in HCC, Neuroendocrine tumours (NETs) and development of novel biomarkers. To this end, Dr Sharma is the Oncology lead for the specialist Hepato-Oncology Clinic, a unique service where patients are jointly managed by a Hepatologist and Medical Oncologist with a view to improving clinical outcomes and promoting research. She is the lead of the liver cancer research group at Imperial and also the Oncology lead for the management of NETs within the Trust.